Report Detail

Pharma & Healthcare Global Tumor Ablation Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2940099
  • |
  • 14 February, 2019
  • |
  • Global
  • |
  • 122 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

This is a minimally invasive surgical method to treat solid cancers, Special probes are used to “burn” or “freeze” cancers without the usual surgery. Computed Tomography (CT), Ultrasound (US) or Magnetic Resonance Imaging (MRI) is used to guide and position the needle probe into the tumor. This requires only a tiny hole, usually less than 3 mm via which the probe is introduced. When the probe is within the cancer it is attached to a generator which “burns” or “freezes” the cancer.

Scope of the Report:
The United States average price of Tumor Ablation is in the decreasing trend, from 410 K USD/ Unit in 2011 to 403.6 K USD/Unit in 2015. With the situation of United States economy, prices will be in decreasing trend in the following five years.
The classification of Tumor Ablation includes Radiofrequency (RF) Ablation, Microwave Ablation, Cryoablation and others. The proportion of Radiofrequency (RF) Ablation in 2015 is about 50.6%, and the proportion of Microwave Ablation in 2015 is about 21.7%.
Tumor Ablation is application in Liver Cancer, Lung Cancer, Kidney Cancer and Other cancers. The most proportion of Tumor Ablation is used in Lung Cancer, and the market share in 2015 is about 28.5%.
The worldwide market for Tumor Ablation is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Tumor Ablation in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Angiodynamics
Medtronic
Boston Scientific
Galil Medical
Neuwave Medical
Misonix
Merit Medical
Sonacare Medical
EDAP TMS

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Radiofrequency (RF) Ablation
Microwave Ablation
Cryoablation
Other Technologies

Market Segment by Applications, can be divided into
Liver Cancer
Lung Cancer
Kidney Cancer
Others

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tumor Ablation product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Tumor Ablation, with price, sales, revenue and global market share of Tumor Ablation in 2017 and 2018.
Chapter 3, the Tumor Ablation competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tumor Ablation breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Tumor Ablation market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Tumor Ablation sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Tumor Ablation Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Radiofrequency (RF) Ablation
      • 1.2.2 Microwave Ablation
      • 1.2.3 Cryoablation
      • 1.2.4 Other Technologies
    • 1.3 Market Analysis by Applications
      • 1.3.1 Liver Cancer
      • 1.3.2 Lung Cancer
      • 1.3.3 Kidney Cancer
      • 1.3.4 Others
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Angiodynamics
      • 2.1.1 Business Overview
      • 2.1.2 Tumor Ablation Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Angiodynamics Tumor Ablation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Medtronic
      • 2.2.1 Business Overview
      • 2.2.2 Tumor Ablation Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Medtronic Tumor Ablation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Boston Scientific
      • 2.3.1 Business Overview
      • 2.3.2 Tumor Ablation Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Boston Scientific Tumor Ablation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Galil Medical
      • 2.4.1 Business Overview
      • 2.4.2 Tumor Ablation Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Galil Medical Tumor Ablation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Neuwave Medical
      • 2.5.1 Business Overview
      • 2.5.2 Tumor Ablation Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Neuwave Medical Tumor Ablation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Misonix
      • 2.6.1 Business Overview
      • 2.6.2 Tumor Ablation Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Misonix Tumor Ablation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Merit Medical
      • 2.7.1 Business Overview
      • 2.7.2 Tumor Ablation Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Merit Medical Tumor Ablation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Sonacare Medical
      • 2.8.1 Business Overview
      • 2.8.2 Tumor Ablation Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Sonacare Medical Tumor Ablation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 EDAP TMS
      • 2.9.1 Business Overview
      • 2.9.2 Tumor Ablation Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 EDAP TMS Tumor Ablation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Tumor Ablation Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Tumor Ablation Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Tumor Ablation Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Tumor Ablation Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Tumor Ablation Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Tumor Ablation Market Analysis by Regions

    • 4.1 Global Tumor Ablation Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Tumor Ablation Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Tumor Ablation Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Tumor Ablation Sales and Growth Rate (2014-2019)
    • 4.3 Europe Tumor Ablation Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Tumor Ablation Sales and Growth Rate (2014-2019)
    • 4.5 South America Tumor Ablation Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Tumor Ablation Sales and Growth Rate (2014-2019)

    5 North America Tumor Ablation by Country

    • 5.1 North America Tumor Ablation Sales, Revenue and Market Share by Country
      • 5.1.1 North America Tumor Ablation Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Tumor Ablation Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Tumor Ablation Sales and Growth Rate (2014-2019)
    • 5.3 Canada Tumor Ablation Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Tumor Ablation Sales and Growth Rate (2014-2019)

    6 Europe Tumor Ablation by Country

    • 6.1 Europe Tumor Ablation Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Tumor Ablation Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Tumor Ablation Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Tumor Ablation Sales and Growth Rate (2014-2019)
    • 6.3 UK Tumor Ablation Sales and Growth Rate (2014-2019)
    • 6.4 France Tumor Ablation Sales and Growth Rate (2014-2019)
    • 6.5 Russia Tumor Ablation Sales and Growth Rate (2014-2019)
    • 6.6 Italy Tumor Ablation Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Tumor Ablation by Country

    • 7.1 Asia-Pacific Tumor Ablation Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Tumor Ablation Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Tumor Ablation Revenue and Market Share by Country (2014-2019)
    • 7.2 China Tumor Ablation Sales and Growth Rate (2014-2019)
    • 7.3 Japan Tumor Ablation Sales and Growth Rate (2014-2019)
    • 7.4 Korea Tumor Ablation Sales and Growth Rate (2014-2019)
    • 7.5 India Tumor Ablation Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Tumor Ablation Sales and Growth Rate (2014-2019)

    8 South America Tumor Ablation by Country

    • 8.1 South America Tumor Ablation Sales, Revenue and Market Share by Country
      • 8.1.1 South America Tumor Ablation Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Tumor Ablation Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Tumor Ablation Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Tumor Ablation Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Tumor Ablation Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Tumor Ablation by Countries

    • 9.1 Middle East and Africa Tumor Ablation Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Tumor Ablation Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Tumor Ablation Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Tumor Ablation Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Tumor Ablation Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Tumor Ablation Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Tumor Ablation Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Tumor Ablation Sales and Growth Rate (2014-2019)

    10 Global Tumor Ablation Market Segment by Type

    • 10.1 Global Tumor Ablation Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Tumor Ablation Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Tumor Ablation Revenue and Market Share by Type (2014-2019)
    • 10.2 Radiofrequency (RF) Ablation Sales Growth and Price
      • 10.2.1 Global Radiofrequency (RF) Ablation Sales Growth (2014-2019)
      • 10.2.2 Global Radiofrequency (RF) Ablation Price (2014-2019)
    • 10.3 Microwave Ablation Sales Growth and Price
      • 10.3.1 Global Microwave Ablation Sales Growth (2014-2019)
      • 10.3.2 Global Microwave Ablation Price (2014-2019)
    • 10.4 Cryoablation Sales Growth and Price
      • 10.4.1 Global Cryoablation Sales Growth (2014-2019)
      • 10.4.2 Global Cryoablation Price (2014-2019)
    • 10.5 Other Technologies Sales Growth and Price
      • 10.5.1 Global Other Technologies Sales Growth (2014-2019)
      • 10.5.2 Global Other Technologies Price (2014-2019)

    11 Global Tumor Ablation Market Segment by Application

    • 11.1 Global Tumor Ablation Sales Market Share by Application (2014-2019)
    • 11.2 Liver Cancer Sales Growth (2014-2019)
    • 11.3 Lung Cancer Sales Growth (2014-2019)
    • 11.4 Kidney Cancer Sales Growth (2014-2019)
    • 11.5 Others Sales Growth (2014-2019)

    12 Tumor Ablation Market Forecast (2019-2024)

    • 12.1 Global Tumor Ablation Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Tumor Ablation Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Tumor Ablation Market Forecast (2019-2024)
      • 12.2.2 Europe Tumor Ablation Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Tumor Ablation Market Forecast (2019-2024)
      • 12.2.4 South America Tumor Ablation Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Tumor Ablation Market Forecast (2019-2024)
    • 12.3 Tumor Ablation Market Forecast by Type (2019-2024)
      • 12.3.1 Global Tumor Ablation Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Tumor Ablation Market Share Forecast by Type (2019-2024)
    • 12.4 Tumor Ablation Market Forecast by Application (2019-2024)
      • 12.4.1 Global Tumor Ablation Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Tumor Ablation Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Tumor Ablation . Industry analysis & Market Report on Tumor Ablation is a syndicated market report, published as Global Tumor Ablation Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Tumor Ablation market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,780.52
      4,170.78
      5,561.04
      3,257.28
      4,885.92
      6,514.56
      547,682.40
      821,523.60
      1,095,364.80
      290,545.20
      435,817.80
      581,090.40
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report